BTG projects 16 percent sales growth for Raia Drogasil stock

Published on 10/16/2026 at 02:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

BTG Pactual projects 16 percent sales growth and 10 percent same-store growth for Raia Drogasil. Results are due November 3, 2026.

Growth thesis and reporting date

On October 9, 2026, BTG Pactual projected 16 percent sales growth and 10 percent same-store growth.
Second-quarter 2026 revenue reached BRL 11.1 billion, while net income totaled BRL 424.5 million.
Raia Drogasil's next earnings date is estimated for November 3, 2026.

Raia Drogasil, BRRADLACNOR0, Illustration mit AI erstellt.

Raia Drogasil stock is the defensive pharmacy retailer favored by BTG Pactual, which projected 16 percent sales growth and 10 percent same-store growth in a report dated October 9, 2026. The view places the company among Brazilian retailers that can expand without relying on a broad recovery in consumer spending.

BTG sees resilient pharmacy demand

According to Exame on October 9, 2026, BTG Pactual classified RD Saude among Brazil's more resilient retail names. The bank's forecast of 10 percent same-store growth gives the thesis a measurable operating anchor, while the 16 percent sales projection points to continued expansion despite pressure from electronic commerce and GLP-1 product mix.

The latest reported quarter also supplies scale. Raia Drogasil generated BRL 11.1 billion in revenue in the second quarter of 2026 and BRL 424.5 million in net income, according to the standardized financial statement for that period. The second-quarter revenue was 4.67 percent higher than BRL 10.6 billion in the first quarter, while net income rose 167.07 percent from BRL 159.0 million. BTG Pactual also reported adjusted second-quarter net income of BRL 424 million and digital sales of BRL 3.9 billion, up 52 percent year over year.

Three milestones define the thesis

On September 18, 2026, BTG Pactual said digital sales represented 31 percent of retail sales and that the company operated about 3,700 stores. On October 6, 2026, the bank listed a BRL 30.00 price target and a buy recommendation for RADL3. On October 9, 2026, its retail preview supplied the latest operating forecast, with 16 percent sales growth and 10 percent same-store growth. BTG Pactual identified online competition and GLP-1-related gross-margin pressure as key risks.

When are the next results due?

The next reporting date is estimated for November 3, 2026, according to MarketBeat. The date gives investors a clear checkpoint for testing whether the projected sales growth is translating into earnings and margin performance.

Stock trades in Brazilian reais

Raia Drogasil was last at BRL 20.59 on October 15, 2026 at 5:05 p.m. BRT on B3. Its market capitalization was BRL 36.0 billion as of October 15, 2026, while the company is classified in healthcare and medical pharmaceuticals.